NYSE · Health Information Services · USD
Phreesia, Inc. (PHR) Stock Analysis
Phreesia, Inc. (PHR) is a Health Information Services stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
PHR Key Statistics
As of Sep 4, 2026Trading
- Open
- $11.08
- Previous Close
- $11.10
- Day's Range
- 10.72–11.15
- 52-Week Range
- 7.77–30.43
- Volume
- 807.90K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.86
Valuation
- Market Cap
- $679.06M
- P/E Ratio
- 60.78
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 6.81
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.34
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.18
Financials (FY)
- Revenue (FY)
- $480.59M+14.48%
- Net Income (FY)
- $2.31M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.06%
- Shares Outstanding
- 62.07M
- 1-Year Return
- −64.95%
Dividend and dates
- Avg Volume
- 893.75K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
PHR Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −35.34% |
| 2025 | −32.75% |
| 2024 | +8.68% |
| 2023 | −28.46% |
| 2022 | −22.32% |
| 2021 | −23.22% |
| 2020 | +103.68% |
| 2019 (partial year) | +6.22% |
As of September 4, 2026.
PHR Revenue and Earnings by Fiscal Year
FY ends January| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $480.59M | $2.31M | 0.5% |
| 2024 | $419.81M | −$58.53M | −13.9% |
| 2023 | $356.30M | −$136.89M | −38.4% |
| 2022 | $280.91M | −$176.15M | −62.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $480.59M | $326.47M | −$6.61M | $2.31M | 0.5% |
| 2024 | $419.81M | $284.88M | −$58.10M | −$58.53M | −13.9% |
| 2023 | $356.30M | $232.29M | −$136.48M | −$136.89M | −38.4% |
| 2022 | $280.91M | $171.64M | −$176.55M | −$176.15M | −62.7% |
Annual figures as reported, in the company's reporting currency. As of January 31, 2026.
PHR Valuation vs Health Information Services Median
Median of 53 stocks| Metric | PHR | Health Information Services median | vs median |
|---|---|---|---|
| P/E | 60.78 | 41.13 | 48% above |
| P/S ratio | 1.34 | 2.66 | 50% below |
| Profit margin | 2.06% | 0.00% | 2.1 pts above |
Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Baird Maintains Neutral on Phreesia, Raises Price Target to $11
BenzingaPhreesia Files Shelf Prospectus For Offering; Size Not Disclosed
BenzingaThese Analysts Revise Their Forecasts On Phreesia After Q2 Results
BenzingaRBC Capital Reiterates Outperform on Phreesia, Maintains $19 Price Target
BenzingaWells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10
BenzingaNeedham Reiterates Buy on Phreesia, Maintains $14 Price Target
Benzinga
All 12 articles ↓Show fewer ↑
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
SeekingAlphaTranscript: Phreesia Q2 2027 Earnings Conference Call
BenzingaPhreesia Affirms FY2027 Sales Guidance of $510.000M-$520.000M vs $515.008M Est
BenzingaPhreesia Q2 EPS $0.03 Misses $0.10 Estimate, Sales $129.458M Beat $129.069M Estimate
BenzingaNeedham Reiterates Buy on Phreesia, Maintains $14 Price Target
BenzingaPhreesia Sets Release Date for Fiscal Second Quarter 2027 Results
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$44.54B
BTSGBrightSpring Health Services, Inc.
$12.02B
TEMTempus AI, Inc.
$11.66B
HQYHealthEquity, Inc.
$7.95B
HNGEHinge Health, Inc.
$7.45B
WAYWaystar Holding Corp.
$4.81B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B









